#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastric cancer Infertility female Haemophagocytic lymphohistiocytosis Fibrosarcoma Cholangiocarcinoma Chronic myelomonocytic leukaemia Barth syndrome ABO haemolytic disease of newborn Hepatic cirrhosis Acquired haemophilia Neuronal ceroid lipofuscinosis Rhabdoid tumour Pemphigoid Acute myeloid leukaemia Henoch-Schonlein purpura More trials…

    Learn about Rare Diseases

    Synovial sarcoma recurrent – Diagnostics Noonan syndrome – Life with Disease Sarcoidosis – Basic Information Ehlers-Danlos syndrome – Diagnostics Aicardi-Goutieres syndrome – Trials in Disease Sarcoidosis – Life with Disease Glycogen storage disease type V – Diagnostics Friedreich’s ataxia – Diagnostics Leiomyosarcoma Hypereosinophilic syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Platelet Concentrate Sodium Iodide (131I) Mps-215 Oxazepam Ulotaront Ferumoxytol LY3537031 VRDN-003 AB521 R2R01 Follitropin Delta L-SERINE L-Arginine Hydrochloride Mirvetuximab Soravtansine Citric Acid Brimonidine Tartrate Clemastine Fumarate Poltreg-T1D Hydroxyzine Hydrochloride Marstacimab More therapies…

    Learn about Your Condition

    Nodular melanoma Retinoblastoma Vaginal haemorrhage Blood iron increased Medullary thyroid cancer Anal fistula Angiopathy Erythema Malignant melanoma Cartilage injury Pemphigoid Thalassaemia alpha Bile duct adenocarcinoma Pulmonary fibrosis Polycystic liver disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin wrinkling

  • Study on the Effectiveness of Clostridium Botulinum Neurotoxin Type A for Reducing Wrinkles in Adults

    Recruiting

    4 1 1
    Investigated Diseases:
    • Skin wrinkling
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    The Netherlands

  • Study on the Safety and Effectiveness of IPN10200 and Botulinum Toxin Type A for Adults with Moderate to Severe Upper Facial Lines

    Recruiting

    2 1 1
    Investigated Diseases:
    • Skin wrinkling
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    • Clostridium Botulinum, Neurotoxin Serotype A/B
    France Germany

  • Corabotase for Moderate to Severe Glabellar Lines in Adults

    Recruiting

    3 1
    Investigated Drugs:
    • Clostridium Botulinum, Neurotoxin Serotype A/B
    France Germany

  • Study Comparing the Effectiveness and Safety of Botulinum Toxin Type A Products for Treating Frown Lines in Adults

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Skin wrinkling
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Botulinum Toxin Type A – Haemagglutinin Complex
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    The Netherlands

  • Study on the Safety and Effectiveness of Dantrolene Sodium and Botulinum Toxin Type A for Treating Severe Glabellar Lines in Adults

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Skin wrinkling
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Dantrolene Sodium
    • Sodium Chloride
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!